While injection of an HDAC3 inhibitor into R62 mice seems to be effective in restoring the expression of genes that have been compromised by HD [16], the genetic knockdown of HDAC3 did not alter the phenotypic and pathological appearance of the same mice [19]. This evidence concerns the gene HDAC3 and Huntington disease.